Xetra

SCHOTT Pharma AG & Co. KGaA

ISIN DE000A3ENQ51Filings at the BaFin

At a glance

Most recent filing on February 12, 2026 — an open-market purchase by Mayer, Reinhard on Feb 12, 2026.

We hold 3 visible filings, going back to December 18, 2025.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

All 3 shown

This page is free to read, and it stops after 3 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Derr, Dr. Torsten Supervisory board
€110,089Open-market buy
TradedFeb 11, 2026FiledFeb 12, 2026
Mayer, Reinhard Management board
€50,655Open-market buy
TradedFeb 12, 2026FiledFeb 12, 2026
Mayer, Reinhard Management board
€44,779Open-market buy
TradedDec 18, 2025FiledDec 18, 2025